neeraj chhabra

Dr. neeraj chhabra

orcid

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 April 2021 in Journal of Medical Toxicology
Verified
Journal Article
Closed access
PDF file
NCneeraj chhabra
neeraj chhabra
JKJoseph Kennedy
Joseph Kennedy

1 April 2018 in The Journal of Emergency Medicine
Verified
Journal Article
Closed access
NCneeraj chhabra
neeraj chhabra
RGRenee P. Gimbar
Renee P. Gimbar
LWLisa M. Walla
Lisa M. Walla
TTTrevonne M. Thompson
Trevonne M. Thompson

5 April 2021 in Journal of Medical Toxicology
Verified
Journal Article
Closed access
PDF file
NCneeraj chhabra
neeraj chhabra
JKJoseph Kennedy
Joseph Kennedy

1 April 2022 in MMWR. Morbidity and Mortality Weekly Report
Verified
Journal Article
Open access
NCneeraj chhabra
neeraj chhabra
MMMojde Mir
Mojde Mir
MHMiao Jenny Hua
Miao Jenny Hua
SBSarah Berg
Sarah Berg
JNJuleigh Nowinski-Konchak
Juleigh Nowinski-Konchak
KHKeiki Hinami
Keiki Hinami
This report describes Xylazine-related deaths in Cook County, Illinois

23 June 2017 in Clinical Toxicology
Verified
Journal Article
Closed access
NCneeraj chhabra
neeraj chhabra
CDCarol DesLauriers
Carol DesLauriers
MWMichael Wahl
Michael Wahl
SBSean M. Bryant
Sean M. Bryant
Background: Bupropion toxicity is characterized by central nervous system and cardiovascular toxicity. Intravenous lipid emulsion (ILE) has been suggested as a treatment by some for the treatment of refractory bupropion toxicity. This recommendation is based largely on published case reports and cases presented at scientific meetings. The objective of this study is to characterize the outcomes of patients with suspected bupropion toxicity in which ILE was administered and the indications for its use. Methods: Electronic records from one regional poison center were searched for intentional bupropion ingestions from 1 January 2009 through 31 December 2015. Cases in which ILE was administered or death was listed as the outcome were further analyzed. Results: There were 1274 cases of suspected bupropion ingestion reported during the study period with 14 reported deaths. Nine cases of ILE administration were identified. Of these, four patients expired and five survived. One of the survivors had neurologic sequelae necessitating placement in a long-term care facility. Patient complications after ILE administration were common and included continued hypotension in 7 cases, recurrent seizures in 3 patients, ARDS in two patients, and renal failure in one patient. Conclusions: The high mortality and complication rate after ILE in this study sample does not reflect the positive outcome benefit seen in previous published case reports. Further characterization of the efficacy and complications of ILE in bupropion toxicity is needed.

3 September 2024 in JAMA Network Open
Verified
Journal Article
Open access
PDF file
NCneeraj chhabra
neeraj chhabra
DSDale Smith
Dale Smith
GDGrayson Dickinson
Grayson Dickinson
LCLily Caglianone
Lily Caglianone
RTR. Andrew Taylor
R. Andrew Taylor
NKNiranjan S. Karnik
Niranjan S. Karnik
Increasing the availability of buprenorphine is an important component of the public health response to the opioid epidemic. As a low-barrier point of contact, emergency departments (EDs) represent a critical setting for buprenorphine initiation, although practices are varied, with local disparities in buprenorphine initiation.1-3